VERU INC
For the period ended Mar 31, 2024. Filed May 8, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 8, 2024
VERU$2.12-3.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Balance Sheets
| March 31, | September 30, | |
|---|---|---|
| 2024 | 2023 (Restated) | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $34,738,038 | $9,625,494 |
| Accounts receivable, net | 2,785,331 | 4,506,508 |
| Inventories, net | 4,804,665 | 6,697,117 |
| Prepaid research and development costs | 924,583 | 1,006,252 |
| Prepaid expenses and other current assets | 1,884,684 | 1,097,851 |
| Total current assets | 45,137,301 | 22,933,222 |
| Plant and equipment, net | 1,534,196 | 1,652,732 |
| Operating lease right-of-use assets | 3,947,417 | 4,332,473 |
| Investments in equity securities | 346,444 | — |
| Deferred income taxes | 12,635,927 | 12,707,419 |
| Goodwill | 6,878,932 | 6,878,932 |
| Other assets | 1,320,142 | 1,518,313 |
| Total assets | $71,800,359 | $50,023,091 |
| Liabilities and Stockholders' Equity | ||
| Current liabilities: | ||
| Accounts payable | $2,464,135 | $12,931,172 |
| Accrued compensation | 2,683,214 | 990,609 |
| Accrued expenses and other current liabilities | 2,425,385 | 1,987,738 |
| Residual royalty agreement liability, short-term portion | 950,600 | 864,623 |
| Operating lease liability, short-term portion | 1,043,029 | 1,036,590 |
| Total current liabilities | 9,566,363 | 17,810,732 |
| Residual royalty agreement liability, long-term portion | 8,775,284 | 8,870,136 |
| Operating lease liability, long-term portion | 3,262,818 | 3,634,114 |
| Other liabilities | 4,986,250 | 29,948 |
| Total liabilities | 26,590,715 | 30,344,930 |
| Commitments and contingencies (Note 12) | ||
| Stockholders' equity: | ||
| Preferred stock; no shares issued and outstanding at March 31, 2024 and September 30, 2023 | — | — |
| Common stock, par value $0.01 per share; 308,000,000 shares authorized, 148,564,890 and 93,966,402 shares issued and 146,381,186 and 91,782,698 shares outstanding at March 31, 2024 and September 30, 2023, respectively | 1,485,649 | 939,664 |
| Additional paid-in-capital | 327,182,257 | 283,894,830 |
| Accumulated other comprehensive loss | (581,519) | (581,519) |
| Accumulated deficit | (275,070,138) | (256,768,209) |
| Treasury stock, 2,183,704 shares, at cost | (7,806,605) | (7,806,605) |
| Total stockholders' equity | 45,209,644 | 19,678,161 |
| Total liabilities and stockholders' equity | $71,800,359 | $50,023,091 |
| See notes to unaudited condensed consolidated financial statements. | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.